Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome

@article{Minnema2008ExtramedullaryRA,
  title={Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome},
  author={Monique C. Minnema and Niels W. C. J. van de Donk and Sonja Zweegman and Ute Hegenbart and Stefan O. Schonland and Reinier A. P. Raymakers and J. M. J. M. Zijlmans and M. J. Kersten and Gerard Bos and Henk M. Lokhorst},
  journal={Bone Marrow Transplantation},
  year={2008},
  volume={41},
  pages={779-784}
}
Recent literature suggests that after non-myeloablative allogeneic (NMA) stem cell transplantation (SCT), the incidence of extramedullary (EM) relapse in multiple myeloma (MM) patients is increased and that these relapses have a poor prognosis. However, numbers on incidence and treatment outcome are scarce. We collected data from 54 relapsed MM patients from a total group of 172 treated with sequential autologous and allogeneic NMA SCT at seven transplantation centres. There were 43 (79.6… CONTINUE READING
17 Citations
17 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Similar Papers

Loading similar papers…